MDCG Pre-Registration Assessment

No. The MDCG is a group of EU member state authorities and does not issue individual candidate certifications. This is an independent study credential that tests knowledge of the MDR, IVDR and MDCG guidance. Treat it as preparation, not as an official EU qualification.

Those administrative figures are set by the body administering the assessment and change between sessions. This page does not publish a count or time limit because none was supplied. Check the official body's site for the current format before you book.

Passing scores and fees are published by the official body and are not stated here. Do not rely on forum figures. Confirm both directly with the administering organisation, and check whether a retake fee differs from the first attempt.

The difficulty is applied rather than encyclopaedic. Candidates who have only memorised article numbers struggle with scenario items on classification rules and conformity routes. Those who have assembled or reviewed a technical file usually find the documentation and clinical domains more tractable.

Retake policy and validity period are set by the administering body and were not provided for this page. Ask the official body whether there is a waiting period between attempts and whether the credential expires, since regulatory knowledge dates quickly as guidance is revised.

Start with domain 1 (MDR/IVDR structure and MDCG guidance) because every other domain references it. Then take classification and conformity routes, followed by technical documentation. Clinical, PMS and UDI build on those. Leave QMS and risk management until last; they are easier once the documentation requirements are clear.

Confusing MDR and IVDR requirements, misapplying classification rules to borderline devices, treating PMCF as optional, and assuming MDCG guidance is legally binding rather than interpretive. Another frequent error is describing Annex II content generically instead of naming the specific evidence an assessor expects.

You need enough recall to locate a requirement, but questions test what the requirement means. Knowing that clinical evaluation is Article 61 and Annex XIV matters less than being able to judge whether a clinical evaluation report supports the claimed intended purpose.

Read them as an assessor would: identify which article or annex they interpret, what they clarify, and where they leave discretion. Note the revision date, because superseded guidance is a common trap. Practice explaining how a specific position paper would change a conformity assessment decision.

Yes, if you work with devices intended for the EU market or review EU submissions. The content is EU-specific, but non-EU regulatory staff, consultants and notified body reviewers use it to align with MDR and IVDR expectations. Familiarity with local frameworks helps but does not substitute for reading the EU texts.